Kabiven Perifer (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

The mixture supplies a balanced profile of essential and non‑essential amino acids directly into the bloodstream. These amino acids act as building blocks for protein synthesis, replenish nitrogen stores, and support metabolic pathways such as gluconeogenesis. By delivering them intravenously, the formulation bypasses digestive absorption, ensuring rapid availability for cellular processes.

The dose of Kabiven Perifer is individualized. A prescribing clinician determines the volume and infusion rate based on the patient’s weight, metabolic needs, renal and hepatic function, and overall nutritional goals. No fixed regimen can be stated; dosing is adjusted according to laboratory monitoring and clinical response.

The pregnancy category for Kabiven Perifer is listed as unknown. Use during pregnancy or lactation should only occur when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Clinicians must evaluate each case carefully and consider alternative nutrition strategies when appropriate.

To order Kabiven Perifer, submit an enquiry on the product page at gnhindia.com indicating the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the sales team provides pricing, availability, shipping details (including cold‑chain logistics if needed) and assists with import documentation.

Kabiven Perifer offers a comprehensive blend of ten amino acids that matches the profile of many standard commercial amino‑acid admixtures. Compared with some alternatives that contain additional non‑protein calories or different ratios, Kabiven Perifer focuses on essential amino acid provision, making it suitable for patients where precise protein dosing is required. Compatibility and stability are comparable when mixed according to manufacturer guidelines.

Kabiven Perifer must be stored refrigerated at 2‑8 °C. The container should be kept in its original packaging, protected from light, and must not be frozen or shaken. Prior to use, inspect the solution for particulates or discoloration and allow it to reach room temperature if required by the infusion protocol.

Kabiven Perifer is administered intravenously, typically via a peripheral or central venous catheter. The solution is infused over a period defined by the prescribing clinician, often 12‑24 hours, and may be diluted with compatible fluids according to the product label. Infusion pumps are recommended to control the rate and ensure patient safety.

The most serious risks include anaphylactic or severe hypersensitivity reactions, marked hyperglycemia, catheter‑related bloodstream infections, and significant renal or hepatic dysfunction. Prompt recognition of these events and immediate medical intervention are essential. Regular monitoring of vital signs, blood glucose, liver enzymes and renal function helps mitigate these risks.

Kabiven Perifer should be avoided in patients with known hypersensitivity to any of its amino‑acid components, in those with severe inborn errors of amino‑acid metabolism, and in individuals with uncontrolled hypernatremia or severe hepatic failure where amino‑acid load could worsen the condition. Clinicians must assess each patient’s medical history before initiating therapy.